Biotechnology
7 articles
AI Drug Development Surges: In Silico Trials Market Grows Dramatically
Biotech firm Insilico Medicine used artificial intelligence to discover a novel drug candidate for idiopathic pulmonary fibrosis (IPF) and advance it to Phase I clinical trials in under 30 months, acc
What are CRISPR-Cas9 gene editing applications and how do they work?
At the molecular level, the Cas9 protein initiates a double-strand break at a locus just 3-nucleotides upstream of a specific PAM sequence, demonstrating an almost surgical precision in genetic modifi
AI Leaders Urge Stricter Synthetic Biology Regulation
Leaders from OpenAI, Microsoft, and Google DeepMind have publicly urged governments to enact stricter regulations for synthetic biology.
Legend Biotech stock surges on strong Q1 CAR T-cell therapy results
Legend Biotech's stock recently jumped 42% following new data, propelled by early clinical successes in difficult-to-treat cancers and robust sales of its existing CAR-T therapy, CARVYKTI, according t
Alnylam partners with Inceptive Nucleics for AI-driven RNAi therapeutics
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, just committed $30 million upfront and up to $2 billion to Silicon Valley biotech startup Inceptive Nucleics.
Pfizer partners with Innovent Biologics for drug pipeline
Pfizer has committed up to $10.5 billion to a collaboration with Innovent Biologics in China to advance a pipeline of 12 novel therapies.
UW Medicine AI designs novel miniproteins targeting GPCRs
In one mouse study, a designed miniprotein performed comparably to a clinically used drug with fewer side effects, offering a glimpse into safer treatments for human diseases.